- Home
- IOT vs ASND Comparison
IOT vs ASND Comparison
Compare IOT & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IOT | ASND |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8B | 13.6B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | IOT | ASND |
|---|---|---|
| Price | $32.25 | $228.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 16 |
| Target Price | $45.42 | ★ $279.50 |
| AVG Volume (30 Days) | ★ 7.4M | 442.4K |
| Earning Date | 03-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,618,635,000.00 | N/A |
| Revenue This Year | $22.82 | $98.57 |
| Revenue Next Year | $19.72 | $43.22 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.57 | N/A |
| 52 Week Low | $23.38 | $124.06 |
| 52 Week High | $48.41 | $248.60 |
Technical Indicators
Market Signals| Indicator | IOT | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 54.12 | 51.40 |
| Support Level | $31.43 | $214.39 |
| Resistance Level | $35.70 | $233.88 |
| Average True Range (ATR) | 1.54 | 7.95 |
| MACD | -0.20 | 0.19 |
| Stochastic Oscillator | 50.05 | 56.89 |
Price Performance
Historical ComparisonAbout IOT Samsara Inc.
Samsara Inc provides an end-to-end solution for operations. The company's Connected Operations Platform consolidates data from its IoT devices and a growing ecosystem of connected assets and third-party systems, and makes it easy for organizations to access, analyze, and act on data insights using its cloud dashboard, custom alerts and reports, mobile apps, and workflows.. The company derives almost all of its revenue from subscription services. Geographically, it derives a majority of its revenue from the United States. The company's customers ranges from small and medium-sized businesses to state and local governments.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.